Evidence of an X-linked or recessive genetic component to prostate cancer risk.
about
Prostate cancer: 3. Individual risk factorsEvaluation of linkage and association of HPC2/ELAC2 in patients with familial or sporadic prostate cancerLinkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.Common sequence variants on 2p15 and Xp11.22 confer susceptibility to prostate cancerDietary fat and prostate cancer: current status.Chromosomal basis of adenocarcinoma of the prostate.X-linked tumor suppressors: perplexing inheritance, a unique therapeutic opportunity.Model-free linkage analysis with covariates confirms linkage of prostate cancer to chromosomes 1 and 4.Segregation analyses of 1,476 population-based Australian families affected by prostate cancer.An epidemiological reappraisal of the familial aggregation of prostate cancer: a meta-analysisGenetics of prostate cancer: too many loci, too few genesCurrent status of linkage studies in hereditary prostate cancer.Analysis of the prostate cancer-susceptibility locus HPC20 in 172 families affected by prostate cancerA genomic scan of families with prostate cancer identifies multiple regions of interest.Evidence for a prostate cancer-susceptibility locus on chromosome 20.A genome screen of multiplex sibships with prostate cancer.Combined analysis of hereditary prostate cancer linkage to 1q24-25: results from 772 hereditary prostate cancer families from the International Consortium for Prostate Cancer Genetics.Evidence for autosomal dominant inheritance of prostate cancer.Inflation of sibling recurrence-risk ratio, due to ascertainment bias and/or overreporting.Analysis of chromosome 1q42.2-43 in 152 families with high risk of prostate cancer.In Swedish families with hereditary prostate cancer, linkage to the HPC1 locus on chromosome 1q24-25 is restricted to families with early-onset prostate cancerMolecular markers and determinants of prostate cancer metastasis.Fatherhood and incident prostate cancer in a prospective US cohort.Novel perspective: focusing on the X chromosome in reproductive cancers.Applicability of biomarkers in the early diagnosis of prostate cancer.X-chromosome genetics and human cancer.Male reproductive health and prostate cancer riskSegregation analysis of 1,546 prostate cancer families in Finland shows recessive inheritance.The CAG repeat within the androgen receptor gene and its relationship to prostate cancer.Molecular prostate cancer pathology: current issues and achievements.Molecular pathology of prostate cancer.CAG repeat length in the androgen receptor gene is related to age at diagnosis of prostate cancer and response to endocrine therapy, but not to prostate cancer risk.Sibling risks in cancer: clues to recessive or X-linked genes?Androgen receptor polyglutamine repeat number: models of selection and disease susceptibility.Hereditary prostate cancer in African American families: linkage analysis using markers that map to five candidate susceptibility loci.Somatic single hits inactivate the X-linked tumor suppressor FOXP3 in the prostate.Molecular mechanisms involving prostate cancer racial disparity.The evolving role of familial history for prostate cancer.Molecular pathways in prostate cancer.Evidence of independent origin of multiple tumors from patients with prostate cancer.
P2860
Q24535097-441DCC11-E227-46C5-B570-045E715AA7C5Q24536433-6311F679-14C7-4CC3-8F44-62728C8B46E8Q24538779-77475C4C-288F-444F-A6CE-6DDB46BFAF3EQ28943505-8CCCC052-5755-43CA-ADBC-C7B7C51275D0Q33539814-E6410D32-57DC-4D2E-9C5C-1E2614B3FD00Q33704075-AC1B4E7A-BA11-467D-BB91-98E091D35E9CQ33980087-91BCA2BB-717A-411D-960B-837EE8D5260CQ34020687-20909BAC-F474-4616-9F0E-D688E1135D88Q34020691-E5A2DAAA-762F-4FC6-837B-591B274FC9A4Q34071472-32DB5EA9-1307-4FA9-B5E9-0850BBF4B6D7Q34078064-C17B8A7D-CA26-4A58-A4B9-0BA27D6C7E4EQ34078544-A7C66C4C-27B3-4FFB-9233-3AD8931B7BC3Q34113343-8A9DF277-BB08-4459-98E9-627362BC81D5Q34141779-6EECF9D1-5E90-41FD-9FAD-87BB39C9B347Q34141928-081D45CC-0B67-4EE0-A4FD-8969B0B1B435Q34145438-3C90673D-BADB-4861-9495-CF9222024F9FQ34145444-201BB9DE-8D41-408B-B626-00A092C22716Q34385644-DAB699A0-D6A9-43CC-8E4B-F6CC7AFCA8CAQ34386225-328BD85B-1AB9-4855-89B9-94A5B2BB1DC9Q34389363-7AB89DBE-52F7-4455-9BD5-36CF952A1505Q34390802-E017D36E-59A8-4045-94AB-0AEDD41A8CF6Q34465689-244156E2-216B-40F9-AB7A-EF71047FE789Q34734149-039960C2-EF85-42C4-97B4-71C9288C4158Q35553879-96F2497D-7C31-4A6C-8EBF-E6E97F356237Q35821838-E3EEE8C9-5531-4AB5-B729-0DB8DAAE4418Q35852318-7FB10BCE-F744-48F1-9967-14697C065610Q35875365-BFFDA2A8-B98D-442B-932E-B6FED10EFE91Q35933901-9E579BC2-3EDB-4F59-A468-6E30F3F6B65AQ36085009-C0E8DD9B-562A-4F40-933A-02C1A2806AFCQ36194970-28216589-06FF-43EC-9104-620BC642C855Q36249264-32A61DF0-A58D-4E48-9E3D-8E95D46B1D64Q36619671-083D7890-7F87-4CB8-8922-DEE288209F4FQ36622613-51433E51-6437-4F07-BF4D-89D4B056E05CQ36651700-790980C8-B5E9-4115-ADCC-9CE7229CC549Q36696583-68C8330D-0A20-45F5-99EC-21906979AC55Q37378517-DCBEEFDB-364E-4430-9292-3C514E92963EQ37418937-C9C1400C-F031-4846-915B-477FDBB9ACBDQ37793100-9692B8C5-5E44-4075-9BD3-5E235E58403CQ38166735-95C7F65C-16E2-4983-AC50-765BDAB1CBB6Q38529357-1004BFA0-2B2C-4F6C-ABF0-B7429B6223DE
P2860
Evidence of an X-linked or recessive genetic component to prostate cancer risk.
description
1995 nî lūn-bûn
@nan
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
1995年论文
@zh
1995年论文
@zh-cn
name
Evidence of an X-linked or recessive genetic component to prostate cancer risk.
@en
type
label
Evidence of an X-linked or recessive genetic component to prostate cancer risk.
@en
prefLabel
Evidence of an X-linked or recessive genetic component to prostate cancer risk.
@en
P2093
P356
P1433
P1476
Evidence of an X-linked or recessive genetic component to prostate cancer risk.
@en
P2093
P2888
P304
P356
10.1038/NM0895-827
P407
P577
1995-08-01T00:00:00Z
P6179
1017259417